Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 127

Similar articles for PubMed (Select 24102421)

1.

Parathyroidectomy improves cardiovascular outcome in nondiabetic dialysis patients with secondary hyperparathyroidism.

Lin HC, Chen CL, Lin HS, Chou KJ, Fang HC, Liu SI, Hsu CY, Huang WC, Huang CW, Huang CK, Chang TY, Chang YT, Lee PT.

Clin Endocrinol (Oxf). 2014 Apr;80(4):508-15. doi: 10.1111/cen.12333. Epub 2013 Oct 18.

PMID:
24102421
2.

Health state utilities associated with major clinical events in the context of secondary hyperparathyroidism and chronic kidney disease requiring dialysis.

Davies EW, Matza LS, Worth G, Feeny DH, Kostelec J, Soroka S, Mendelssohn D, McFarlane P, Belozeroff V.

Health Qual Life Outcomes. 2015 Jun 30;13(1):90. doi: 10.1186/s12955-015-0266-9.

PMID:
26122041
3.

Parathyroidectomy Is Associated with Reduced Mortality in Hemodialysis Patients with Secondary Hyperparathyroidism.

Ma TL, Hung PH, Jong IC, Hiao CY, Hsu YH, Chiang PC, Guo HR, Hung KY.

Biomed Res Int. 2015;2015:639587. doi: 10.1155/2015/639587. Epub 2015 Apr 23.

4.

Utilization of parathyroidectomy for secondary hyperparathyroidism in end-stage renal disease.

Konstantinidis I, Nadkarni G, Divino CM, Lapsia V.

Clin Kidney J. 2013 Jun;6(3):277-82. doi: 10.1093/ckj/sft028. Epub 2013 Mar 28.

5.

Reduced Stroke Risk After Parathyroidectomy in End-Stage Renal Disease: A 13-Year Population-Based Cohort Study.

Hsu YH, Chen HJ, Shen SC, Tsai WC, Hsu CC, Kao CH.

Medicine (Baltimore). 2015 Jun;94(23):e936. doi: 10.1097/MD.0000000000000936.

PMID:
26061321
6.

Risk factors for severe hypocalcemia after parathyroidectomy in prevalent dialysis patients with secondary hyperparathyroidism.

Tsai WC, Peng YS, Chiu YL, Wu HY, Pai MF, Hsu SP, Yang JY, Tung KT, Chen HY.

Int Urol Nephrol. 2015 Jul;47(7):1203-7. doi: 10.1007/s11255-015-1016-y. Epub 2015 May 30.

PMID:
26025063
7.

Clinical significance of parathyroid intervention on CKD-MBD management.

Ogata H, Mizobuchi M, Koiwa F, Kinugasa E, Akizawa T.

NDT Plus. 2008 Aug;1(Suppl 3):iii9-iii13. doi: 10.1093/ndtplus/sfn080.

8.

The whole-PTH/intact-PTH ratio is a useful predictor of severity of secondary hyperparathyroidism.

Tanaka M, Komaba H, Itoh K, Matsushita K, Matshushita K, Hamada Y, Fujii H, Fukagawa M.

NDT Plus. 2008 Aug;1(Suppl 3):iii59-iii62. doi: 10.1093/ndtplus/sfn089.

9.

Effects of percutaneous ethanol injection therapy on subsequent surgical parathyroidectomy.

Nakamura M, Marui Y, Ubara Y, Nakanishi S, Takemoto F, Takaichi K, Tomikawa S.

NDT Plus. 2008 Aug;1(Suppl 3):iii39-iii41. doi: 10.1093/ndtplus/sfn086.

10.

Percutaneous ethanol injection therapy for advanced renal hyperparathyroidism in Japan: 2004 survey by the Japanese Society for Parathyroid Intervention.

Kakuta T, Fukagawa M, Kitaoka M, Koiwa F, Onoda N, Tominaga Y, Akizawa T, Kurokawa K; Japanese Society for Parathyroid Intervention.

NDT Plus. 2008 Aug;1(Suppl 3):iii21-iii25. doi: 10.1093/ndtplus/sfn082.

11.

Parathyroidectomized patients have impaired capacity of peripheral vascular constriction during hemodialysis.

Silva BC, Moysés RM, Silva VB, Freitas GR, Elias RM.

Hemodial Int. 2015 Apr 28. doi: 10.1111/hdi.12309. [Epub ahead of print]

PMID:
25923250
12.

Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism.

Komaba H, Taniguchi M, Wada A, Iseki K, Tsubakihara Y, Fukagawa M.

Kidney Int. 2015 Mar 18. doi: 10.1038/ki.2015.72. [Epub ahead of print]

PMID:
25786097
13.

Pathophysiology and treatment of nonfamilial hyperparathyroidism.

Lumachi F, Basso SM.

Recent Pat CNS Drug Discov. 2014;9(3):164-72.

PMID:
25643126
14.

Parathyroidectomy improves fracture nonunion in hyperparathyroidism.

Lee F, Lee JJ, Liu TP, Cheng SP.

Am Surg. 2015 Jan;81(1):E36-7. No abstract available.

PMID:
25569061
15.

Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study.

Tentori F, Wang M, Bieber BA, Karaboyas A, Li Y, Jacobson SH, Andreucci VE, Fukagawa M, Frimat L, Mendelssohn DC, Port FK, Pisoni RL, Robinson BM.

Clin J Am Soc Nephrol. 2015 Jan 7;10(1):98-109. doi: 10.2215/CJN.12941213. Epub 2014 Dec 16.

PMID:
25516917
16.

Clinical outcomes after parathyroidectomy in a nationwide cohort of patients on hemodialysis.

Ishani A, Liu J, Wetmore JB, Lowe KA, Do T, Bradbury BD, Block GA, Collins AJ.

Clin J Am Soc Nephrol. 2015 Jan 7;10(1):90-7. doi: 10.2215/CJN.03520414. Epub 2014 Dec 16.

17.

Young age, male sex, and end-stage renal disease with secondary hyperparathyroidism as risk factors for intraoperative hyperkalemia during parathyroidectomy.

Yang YL, Lu HF, Chung KC, Jawan B, Chou FF.

J Clin Anesth. 2015 May;27(3):195-200. doi: 10.1016/j.jclinane.2014.06.015. Epub 2014 Nov 27.

PMID:
25434503
18.

Impaired endothelial function in patients with mild primary hyperparathyroidism improves after parathyroidectomy.

Tuna MM, Doğan BA, Arduç A, Imga NN, Tütüncü Y, Berker D, Güler S.

Clin Endocrinol (Oxf). 2014 Nov 13. doi: 10.1111/cen.12666. [Epub ahead of print]

PMID:
25393455
19.

Outcomes of Total Parathyroidectomy with Autotransplantation versus Subtotal Parathyroidectomy with Routine Addition of Thymectomy to both Groups: Single Center Experience of Secondary Hyperparathyroidism.

Sakman G, Parsak CK, Balal M, Seydaoglu G, Eray IC, Sarıtaş G, Demircan O.

Balkan Med J. 2014 Mar;31(1):77-82. doi: 10.5152/balkanmedj.2014.9544. Epub 2014 Mar 1.

20.

Cardiovascular risk factors in patients with asymptomatic primary hyperparathyroidism.

García-Martín A, Reyes-García R, García-Castro JM, Quesada-Charneco M, Escobar-Jiménez F, Muñoz-Torres M.

Endocrinol Nutr. 2014 Dec;61(10):516-22. doi: 10.1016/j.endonu.2014.05.007. Epub 2014 Aug 6. English, Spanish.

PMID:
25106709
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk